GGrantIndex
Sort

64,565 grants matching drug discovery

Novel Immunoregulatory Therapeutics for Systemic Lupus Erythematosus

$563,659
Andrew Leber · Biotherapeutics, Inc. · R44 · FY2022 · AI

Targeting c-Myc and Proteasome Inhibitor Resistance in Multiple Myeloma

$563,523
Yuan Chen · Beckman Research Institute/City Of Hope · R01 · FY2019 · CA

Small Molecule Therapeutic for Heart Failure

$563,500
Sathyamangla V Prasad · Cleveland Clinic Lerner Com-Cwru · R61 · FY2024 · HL

Assessing the Influence of the Human Lipidome on Risk of Diabetes in a Minority Population

$563,496
Joanne E Curran · University Of Texas Rio Grande Valley · R01 · FY2021 · DK

Optimizing the immune response by targeting the Sts enzymes

$563,489
Nicholas A Carpino · State University New York Stony Brook · R01 · FY2022 · AI

The mechanism of allosteric modulation of glutamate transporters

$563,474
Andreia C K Mortensen · Drexel University · R01 · FY2024 · NS

High throughput screening of orthosteric inhibitors of flavivirus protease

$563,396
Hongmin Li · University Of Arizona · R01 · FY2021 · AI

Tuberculosis epidemiology and novel transmission routes in rural Tanzania

$563,386
Philip C Hopewell · University Of California, San Francisco · U01 · FY2013 · AI

Regulation of Neurodegeneration by Nonpathogenic Cellular Prion Protein and LRP1

$563,313
Steven L. Gonias · University Of California, San Diego · R01 · FY2024 · NS

Regulation of Neurodegeneration by Nonpathogenic Cellular Prion Protein and LRP1

$563,313
Steven L. Gonias · University Of California, San Diego · R01 · FY2025 · NS

Development of an iPSC-derived human hepatocyte platform for drug development.

$563,284
Brian Robert Wamhoff · Hemoshear Therapeutics, Llc · R44 · FY2016 · GM

Defining the Role of Host Factors in Ebola Virus RNA Synthesis

$563,251
Douglas J. Lacount · Washington University · P01 · FY2019 · AI

Defining the Role of Host Factors in Ebola Virus RNA Synthesis

$563,250
Douglas J. Lacount · Washington University · P01 · FY2020 · AI

Mapping the Pharmacogenetic Landscape for Precision Medicine

$563,249
Alan Ashworth · University Of California, San Francisco · U54 · FY2019 · CA

Monitoring of Breast Neoadjuvant Therapy by Thermo- and Photo- Acoustic Tomograph

$563,192
Lihong Wang · Washington University · R01 · FY2012 · CA

SYNTHESIS OF CARBOHYDRATE IMMUNOSTIMULANTS

$563,190
Derek S Tan · Sloan-Kettering Inst Can Research · R01 · FY2011 · GM

SYNTHESIS OF CARBOHYDRATE IMMUNOSTIMULANTS

$563,190
Derek S Tan · Sloan-Kettering Inst Can Research · R01 · FY2012 · GM

Bisphosphonate inhibitors of NRTI excision

$563,164
University Of Pittsburgh At Pittsburgh · R01 · FY2004 · AI

Mid-Scale RNA Synthesis, Purification and Quality Control System

$563,141
Anastasia Khvorova · Univ Of Massachusetts Med Sch Worcester · S10 · FY2015 · OD

Enabling the Accelerated Discovery of Novel Chemical Probes by Integration of Crystallographic, Computational, and Synthetic Chemistry Approaches

$563,072
Alexander Tropsha · Univ Of North Carolina Chapel Hill · R01 · FY2021 · GM

MCSP TORFP NO. NIH-NINDS-20-03: KATRITCH (USC) - BASE EC (PAIN)

$563,025
Keith Barnes · Albany Molecular Research, Inc. · N01 · FY2020 · DA

Neurobiology of non-specific and specific treatment responses in Major Depression

$562,999
Jon-Kar Zubieta · University Of Utah · R01 · FY2017 · MH

Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasma

$562,991
Gordon R. Bernard · Vanderbilt University Medical Center · UL1 · FY2020 · TR

Near-Infrared Fluorescence Nanoparticles for Targeted Optical Imaging

$562,915
Chun Li · University Of Tx Md Anderson Can Ctr · R01 · FY2008 · CA

Vaccina Virus DNA Topoisomerase

$562,903
Stewart H Shuman · Sloan-Kettering Inst Can Research · R37 · FY2008 · GM